[EN] USE OF SUBSTITUTED 2,5-DIAMIDOINDOLES FOR THE TREATMENT OF UROLOGICAL DISEASES [FR] UTILISATION DE 2,5-DIAMIDOINDOLES SUBSTITUES POUR LE TRAITEMENT DE MALADIES UROLOGIQUES
[EN] USE OF SUBSTITUTED 2,5-DIAMIDOINDOLES FOR THE TREATMENT OF UROLOGICAL DISEASES [FR] UTILISATION DE 2,5-DIAMIDOINDOLES SUBSTITUES POUR LE TRAITEMENT DE MALADIES UROLOGIQUES
Use of substituted 2,5-diamidoindoles for the treatment of urological diseases
申请人:Erguden Jens
公开号:US20060183753A1
公开(公告)日:2006-08-17
The present invention relates to the use of 2,5-diamidoindole derivatives for the preparation of medicaments for treating urological disorders in humans and/or animals.RCK 41-Foreign Countries
Substituted 2 5-diamidoindoles as ece inhibitors for the treatment of cardiovascular diseases
申请人:Erguden Jens-Kerim
公开号:US20050038101A1
公开(公告)日:2005-02-17
The invention relates to compounds of formula (I), to a method for the production thereof, and to the use of the same as pharmaceuticals for the treatment of diseases in humans and/or animals.
本发明涉及公式(I)的化合物,其制备方法和将其用作治疗人类和/或动物疾病的药物。
Substituted 2,5-diamidoindoles as ECE inhibitors for the treatment of cardiovascular diseases
申请人:Bayer HealthCare AG
公开号:US07045544B2
公开(公告)日:2006-05-16
The invention relates to compounds of formula (I), to a method for the production thereof, and to the use of the same as pharmaceuticals for the treatment of diseases in humans and/or animals
本发明涉及公式(I)的化合物,其制备方法以及将其用作人类和/或动物疾病治疗药物的用途。
SUBSTITUIERTE 2,5-DIAMIDOINDOLE ALS ECE-INHIBITOREN ZUR BEHANDLUNG VON KARDIOVASKULÄREN ERKRANKUNGEN
申请人:Bayer HealthCare AG
公开号:EP1432415B1
公开(公告)日:2005-12-28
USE OF SUBSTITUTED 2,5-DIAMIDOINDOLES FOR THE TREATMENT OF UROLOGICAL DISEASES